Results 221 to 230 of about 37,266 (235)

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

Lancet, The, 2012
Burkert Pieske, Amil M Shah, Milton Packer   +2 more
exaly  

Spironolactone for Heart Failure with Preserved Ejection Fraction

New England Journal of Medicine, 2014
Bertram Pitt, Marc Pfeffer, Inder S Anand   +2 more
exaly  

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine, 2019
Catherine M Viscoli, Lars Køber, Piotr Ponikowski   +2 more
exaly  

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

New England Journal of Medicine, 2019
Inder S Anand, Carolyn S P Lam, Aldo P Maggioni   +2 more
exaly  

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

New England Journal of Medicine, 2008
Michel Komajda, Michael R Zile
exaly  

Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study

Lancet, The, 2016
Francisco Campelo-Parada, William T Abraham, Josep Rodés-Cabau   +2 more
exaly  

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

New England Journal of Medicine, 2006
Steven J Jacobsen
exaly  

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

New England Journal of Medicine, 1991
Salim Yusuf
exaly  

Heart failure with reduced ejection fraction

Nature Reviews Disease Primers, 2017
Aldo P Maggioni, Barry Greenberg, Tiny Jaarsma   +2 more
exaly  

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Lancet, The, 2003
Salim Yusuf, Karl Swedberg, Christopher B Granger   +2 more
exaly